Qube Research & Technologies LTD Dexcom Inc Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Dexcom Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,720,113 shares of DXCM stock, worth $138 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,720,113
Previous 236,001
628.86%
Holding current value
$138 Million
Previous $26.8 Million
330.84%
% of portfolio
0.18%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding DXCM
# of Institutions
1,014Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.81 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.77 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.44 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.34 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.21 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $31B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...